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C L I N I C A L F O C U S : R E T I N O P A T H Y OF P R E M A T U R I T Y
Editorial: Retinopathy of prematuritythen and now N. R. Cliff Roberton . fo vrn evl y Co nsu I t a n t Neo n u to log is t , Ex -Pves id en t of B A PM RETINOPATHY O F I'I<EMATUKlTY (ROP) is a sequel of hyperoxaemia in premature babies. For reasons that I suspect were more to do with the exigencies of medico-legal activity in the USA, than objective scientific reappraisal of the randomized controlled trials of the 1 9 5 0~, ' .~ the importance of retinal hyperoxaemia became unfashionable during the mid 1980s.' It is once more correctly occupying centre stage as a result of the clinical and experimental studies reviewed by Professors Fielder and Marlow in this issue. Prematurity is also centre stage with the socalled 'new epidemic' of ROP. In this epidemic, extreme prematurity of between 23 and 27 weeks gestational age makes the development of grade 1-11 K O P almost inevitable in the survivors -80% in some series of 24 and 25 week gestation babies;4 indeed this raises the almost philosophical question of whether a condition which is so common is a disease.
Although R O P in the 1990s is primarily a disease of babies of <29 weeks gestation and < 1 .OO kg birthweight, we must not forget that R O P can and does still occur in bigger babies when control of oxygen therapy is substandard. After all, the 90th centile for birthweight at 29 weeks is 1.75 kg, and in studies from the 3 950s-1980s cicatricial R O P was reported in babies of 32-33 weeks gestation and > 1500 g birth-
The methodologies for controlling PaO, have been with us for many years.' How to implement them over the several weeks that ELBW neonates are at risk from KOP does pose problems and controversyparticularly how long umbilical artery catheters can safely be left in situ, and the use of oximetry. I believe Professor Marlow is unduly optimistic about the role of oximetry. With many machines at readings of 95%, the baby will be dangerously hyperoxaemic,"*' one problem being the enormous variability in the accuracy of individual machines. 11'12 Conversely, if the high alarm is set at 9296, for example, and the low alarm 85% to prevent the hypoxaemia now fashionable in the aetiology of ROP, the machines will be alarming frequently, and either ignored or reset. In my view oximeters have no role in that part of the routine monitoring of ELBW neonates intended to prevent ROP,13 and arterial gases mut be obtained either by leaving in the umbilical artery catheters for weeks rather than days or by inserting cannulae into other arteries.
Two of the great conundrums of R O P are firstly that the vast majority of babies exposed to hyperoxaemia (PaO, > 10 kPa or even 12kPa) do not develop even the earlier stages of proliferative ROP, and certainly never go blind, and secondly, that the disease is often strikingly a~yrnmetrical.~'~'~'~ There must, therefore, be something extra which predisposes the unlucky baby or even the unlucky eye to getting KOP. Many past suggestions are reviewed by Professor Marlow: like him I have found them unconvincing. The factors implicated are either accidents of a statistical trawl through retrospectively gathered data, or markers of prolonged oxygen treatment, and thus implicitly the risks of oxygen over-treatment leading to ROP. Alternatively, the complications alter the shape of the oxyhaenioglobin association curve in a way that could give increased tissue oxygenation.
The flavours of the month for these additional factors predisposing to R O P (hypoxia and PaO, variability) are reviewed by Professors Fielder and Marlow. While hypoxia has a long pedigree as an aetiological factor in ROP, as reviewed by Professor Fielder, it does not help in explaining unilateral disease and even greater scepticism is indicated when the topic of fluctuating PaO, values is considered. One of the surpris-ing findings when continuous PaO, catheters were first used was that all ill preterm babies have fluctuating PO, even when clinically apparently stable. "-" So, do babies who get ROP have more variability than those who do not? Very difficult to quantifjr, and I find the two supporting papers1'"* less than convincing. Statistical significance there may be, but is it really clinically significant? Do Cunningham et all8 really expect us to believe that a statistically significant standard deviation for PaO, on week one of 1.19kPa compared with 1.12kPa (0.07kPa = 0.5mmHg) is clinically significantparticularly when measured with an inherently inaccurate device, the transcutaneous PO, monitor! However, the three papers in this issue have two crucial 'take home' messages, both of which I endorse wholeheartedly. Firstly, there is now a consensus view that obsessional control of PaO, in babies <29 weeks gestation will reduce to an absolute minimum the number of cases of threshold grade I11 ROP. If this means preventing hypoxaemia as well as hyperoxaemia so be it. There are, after all, excellent reasons for preventing hypoxaemia compared with only one for preventing hyperoxaemia. Mind you, I thought I had that message 30 years ago.8 Secondly, for those babies unfortunate enough to develop grade 111 threshold disease despite meticulous management, Miss Adams shows that careful clinical surveillance from 32 weeks post-conceptional age followed by laser or cryotherapy should prevent blindness in the majority of cases. That I think is a major change when comparing then with now.
